Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cloudstone Venture


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 3
Average round size
The average size of a deal this fund participated in
Portfolio companies 3
Lead investments 0
Key employees 1

Areas of investment

  • Health Care
  • Biotechnology
  • Health Diagnostics
  • Medical Device
  • Medical

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2017.

The overall number of key employees were 1.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Quantapore, Paragon Genomics The fund has specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Emergency Medicine, Health Care.

The standard case for the fund is to invest in rounds with 5 partakers. Despite the Cloudstone Venture, startups are often financed by China BioPharma Capital I. The meaningful sponsors for the fund in investment in the same round are Wisemont Capital, Tsingyuan Ventures, Sangel Biomedical Venture Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cloudstone Venture:
Typical Co-investors
Cloudstone Venture is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cloudstone Venture:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
aSTART Chiyoda, Japan
Capitole Angels France, Midi-Pyrenees, Toulouse
eYantra Industries Andhra Pradesh, Hyderabad, India
Food AFrica Accelerator Kenya, Nairobi, Nairobi Area
FUTURE NETWORK China, Jiangsu, Nanjing
Guangzhou Shenlong Touzi Guanli Youxian Gongsi China, Guangdong, Guangzhou
Hamilton Lane Bala Cynwyd, Pennsylvania, United States
Ingenio Canada, Montréal, Quebec
Jefferson Partners Canada, Ontario, Toronto
MCIP Holdings Japan, Yamanashi, Yamanashi Prefecture
MTbrain -
Philips Health Technology Ventures Drenthe, Netherlands, Nieuw-amsterdam
PiPEDO HD Japan, Tokyo
Seed Equity Venture Partners Salt Lake City, United States, Utah
Susquehanna Growth Equity Pennsylvania, Philadelphia, United States
The Taylor family -
United States African Development Foundation District of Columbia, United States, Washington
vSpring Capital Salt Lake City, United States, Utah
Walgreens Boots Alliance Deerfield, Illinois, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Health Diagnostics
Medical Device
30 Apr 2020 Mountain View, California, United States


Health Care
$17M19 Jul 2018 California, United States

Paragon Genomics

Emergency Medicine
Health Care
Information Technology
$8M12 Sep 2017 Hayward, California, United States
Zenflow Raises $24M in Series B Funding

– Zenflow, Inc. is a South San Francisco, CA-based medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH).
– Company raised $24m in Series B financing round.
– The round was led by Invus Opportunities with participation from F-Prime Capital, Medical Technology Venture Partners, Golden Seeds, Astia Angels, CloudStone Capital, SV Tech Ventures, and others.
– The new investment will be used to further develop the company’s Spring® System, a minimally invasive treatment option for patients who suffer debilitating symptoms due to enlarged prostate.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cloudstone Venture?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: